The Latest Breaking News from Surf

Indian-origin mathematician gifts summer fellowship to alma mater Caltech honoring parents: 'We'll figure it out. Jump!'

Sukhada Fadnavis, an Indian-origin mathematician, has decided to start a fellowship at her alma mater Caltech (California Institute of Technology), in the name of her parents -- Shubhangi and Sharad Fadnavis Summer Undergraduate Research Fellowship. The fellowship will support undergraduate students conducting research through the Institute's signature program.

The Times of India · Jun 19

Exclusive: Surf, an AI platform just for for crypto, raises $15 million

The startup is backed by Pantera, Coinbase and DCG

Fortune · Dec 10, 2025

Udaan actor Kavita Chaudhary, India’s beloved ‘Lalitaji’, dies of heart attack at 67

Kavita Chaudhary, who played the role of IPS officer Kalyani Singh in Udaan, passed away in Amritsar after suffering a heart attack. She was 67. Read further on Dynamite News:

Dynamite News · Feb 17, 2024

SuperCupNI 2022 Minor final: Surf Select boss proud of history-making side

The American side came from behind to beat Glentoran in Friday's Minor final

Belfast Live · Jul 29, 2022

5 Oncology Stocks Wall Street Predicts Will Rally 135% or More

The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of quality oncology…

StockNews.com · May 31, 2022

Surface Oncology: Q1 Earnings Insights

  Surface Oncology (NASDAQ:SURF) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Surface Oncology reported an EPS of $0.13.

Benzinga · May 9, 2022

Surface Oncology Highlights New SRF388 Data At AACR Meeting

Surface Oncology Inc (NASDAQ: SURF) announced the presentation of new preclinical and translational data for SRF388, a first-in-class antibody targeting IL-27, at the American Association for Cancer Research (AACR) Annual Meeting 2022.

Benzinga · Apr 11, 2022